Refocused NetScientific Set For New Cash Injection To Boost Portfolio Investments
This article was originally published in Clinica
AIM-listed NetScientific could see by the end of this week an additional £20m in its coffers, funds that will be used to take the healthcare tech investor’s most promising portfolio companies to commercialization and potential exits.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.